XUE

N-[(3-chloro-4-cyanophenyl)methyl]-2-{7-[1-(methoxyacetyl)piperidin-4-yl]-1-oxo-3,4-dihydroisoquinolin-2(1H)-yl}-N-methylacetamide

Created:	2023-06-08
Last modified:	2024-12-18

Find Related PDB Entry
1 entries where XUE is found as a standalone ligand

Find related ligands:

Similar Ligands (Stereospecific) Similar Ligands (including Stereoisomers) Similar Ligands (Quick Screen) Similar Ligands (Substructure Stereospecific) Similar Ligands (Substructure including Stereoisomers)

Chemical Details
Formal Charge	0
Atom Count	68
Chiral Atom Count	0
Bond Count	71
Aromatic Bond Count	12

2D diagram of XUE

Toggle Hydrogen Toggle Labels

Chemical Component Summary
Name	N-[(3-chloro-4-cyanophenyl)methyl]-2-{7-[1-(methoxyacetyl)piperidin-4-yl]-1-oxo-3,4-dihydroisoquinolin-2(1H)-yl}-N-methylacetamide
Systematic Name (OpenEye OEToolkits)	~{N}-[(3-chloranyl-4-cyano-phenyl)methyl]-2-[7-[1-(2-methoxyethanoyl)piperidin-4-yl]-1-oxidanylidene-3,4-dihydroisoquinolin-2-yl]-~{N}-methyl-ethanamide
Formula	C₂₈ H₃₁ Cl N₄ O₄
Molecular Weight	523.023
Type	NON-POLYMER

Chemical Descriptors
Type	Program	Version	Descriptor
SMILES	ACDLabs	12.01	O=C(COC)N1CCC(CC1)c1ccc2CCN(CC(=O)N(C)Cc3ccc(C#N)c(Cl)c3)C(=O)c2c1
SMILES	CACTVS	3.385	COCC(=O)N1CCC(CC1)c2ccc3CCN(CC(=O)N(C)Cc4ccc(C#N)c(Cl)c4)C(=O)c3c2
SMILES	OpenEye OEToolkits	2.0.7	CN(Cc1ccc(c(c1)Cl)C#N)C(=O)CN2CCc3ccc(cc3C2=O)C4CCN(CC4)C(=O)COC
Canonical SMILES	CACTVS	3.385	COCC(=O)N1CCC(CC1)c2ccc3CCN(CC(=O)N(C)Cc4ccc(C#N)c(Cl)c4)C(=O)c3c2
Canonical SMILES	OpenEye OEToolkits	2.0.7	CN(Cc1ccc(c(c1)Cl)C#N)C(=O)CN2CCc3ccc(cc3C2=O)C4CCN(CC4)C(=O)COC
InChI	InChI	1.06	InChI=1S/C28H31ClN4O4/c1-31(16-19-3-4-23(15-30)25(29)13-19)26(34)17-33-12-9-21-5-6-22(14-24(21)28(33)36)20-7-10-32(11-8-20)27(35)18-37-2/h3-6,13-14,20H,7-12,16-18H2,1-2H3
InChIKey	InChI	1.06	IRBLNQWOWNBZLI-UHFFFAOYSA-N

Related Resource References

Resource Name	Reference
PubChem	172635982

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.